Recent Quarter Total Invested
$32.89 M
Recent Quarter Institutional Ownership Percentage
24.43%
Total Invested of Last Quarter
$28.98 M
Ownership Percentage of Last Quarter
25.18%
Akoya Biosciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLUE WATER LIFE SCIENCE ADVISORS, LP | 11/14/2024 | 4.70 M | $12.78 M | 0.00% | 9.49% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 1.58 M | $4.30 M | 100.00% | 3.19% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 11/14/2024 | 790,000 | $2.15 M | 125.71% | 1.60% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 561,609 | $1.53 M | -0.09% | 1.13% |
STATE STREET CORP | 11/14/2024 | 453,296 | $1.23 M | 4.22% | 0.92% |
PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 376,131 | $1.02 M | 0.16% | 0.76% |
GSA CAPITAL PARTNERS LLP | 11/05/2024 | 310,669 | $845,000 | 87.41% | 0.63% |
SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 271,400 | $738,208 | -7.79% | 0.55% |
PEDDOCK CAPITAL ADVISORS, LLC | 10/08/2024 | 234,720 | $638,438 | -0.09% | 0.47% |
MORGAN STANLEY | 11/14/2024 | 170,411 | $463,518 | 57.52% | 0.34% |
OSTERWEIS CAPITAL MANAGEMENT INC | 11/14/2024 | 126,131 | $343,076 | 0.00% | 0.25% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 105,600 | $287,232 | -41.20% | 0.21% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 63,002 | $171,365 | -64.18% | 0.13% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 56,382 | $153,359 | -16.43% | 0.11% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 52,889 | $143,858 | 296.89% | 0.11% |
CITADEL ADVISORS LLC | 11/14/2024 | 51,798 | $140,891 | 566.47% | 0.10% |
ZWJ INVESTMENT COUNSEL INC | 10/16/2024 | 45,275 | $123,148 | -2.58% | 0.09% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 40,827 | $111,049 | 0.00% | 0.08% |
BARCLAYS PLC | 11/19/2024 | 39,472 | $107,000 | 320.94% | 0.08% |
ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 33,050 | $89,896 | 0.00% | 0.07% |
RHUMBLINE ADVISERS | 11/12/2024 | 30,461 | $82,847 | 6.02% | 0.06% |
TRANSCEND CAPITAL ADVISORS, LLC | 10/15/2024 | 27,600 | $75,072 | 100.00% | 0.06% |
CITADEL ADVISORS LLC | 11/14/2024 | 24,100 | $65,552 | 265.15% | 0.05% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 20,834 | $56,668 | 0.84% | 0.04% |
HIGHTOWER ADVISORS, LLC | 11/14/2024 | 20,200 | $55,000 | -25.74% | 0.04% |
REGAL INVESTMENT ADVISORS LLC | 11/12/2024 | 17,729 | $48,223 | -5.50% | 0.04% |
XTX TOPCO LTD | 11/14/2024 | 15,380 | $41,834 | -18.98% | 0.03% |
AMERIPRISE FINANCIAL INC | 11/14/2024 | 15,300 | $41,616 | -22.34% | 0.03% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 14,922 | $40,588 | 31.02% | 0.03% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 14,491 | $39,000 | 100.00% | 0.03% |
COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 14,208 | $38,646 | -0.61% | 0.03% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 13,503 | $36,728 | 100.00% | 0.03% |
JPMORGAN CHASE & CO | 11/08/2024 | 12,220 | $33,238 | 2.95% | 0.02% |
NEW YORK STATE COMMON RETIREMENT FUND | 10/28/2024 | 11,802 | $32,000 | 0.00% | 0.02% |
TWO SIGMA SECURITIES, LLC | 11/14/2024 | 11,087 | $30,157 | 100.00% | 0.02% |
WELLS FARGO & COMPANY/MN | 11/13/2024 | 8,183 | $22,258 | -3.81% | 0.02% |
UBS GROUP AG | 11/14/2024 | 7,044 | $19,160 | -13.70% | 0.01% |
ROYAL BANK OF CANADA | 11/14/2024 | 3,219 | $9,000 | 15.01% | 0.01% |
LEGAL & GENERAL GROUP PLC | 11/14/2024 | 2,510 | $6,815 | 0.00% | 0.01% |
GROUP ONE TRADING, L.P. | 11/14/2024 | 2,043 | $5,557 | 0.00% | 0.00% |
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 11/14/2024 | 1,925 | $5,236 | 0.00% | 0.00% |
SIT INVESTMENT ASSOCIATES INC | 11/13/2024 | 1,854 | $5,000 | 0.00% | 0.00% |
AMERITAS INVESTMENT PARTNERS, INC. | 11/13/2024 | 1,199 | $3,261 | 0.00% | 0.00% |
RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 568 | $1,545 | 64.16% | 0.00% |
AMALGAMATED BANK | 10/30/2024 | 465 | $1,000 | 0.00% | 0.00% |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 11/14/2024 | 400 | $1,088 | 0.00% | 0.00% |
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | 11/08/2024 | 322 | $875 | 0.00% | 0.00% |
CWM, LLC | 10/08/2024 | 264 | $1,000 | 100.00% | 0.00% |
STRS OHIO | 11/01/2024 | 200 | $544 | 0.00% | 0.00% |
CAPITAL PERFORMANCE ADVISORS LLP | 11/01/2024 | 142 | $386 | 100.00% | 0.00% |
Akoya Biosciences, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of AKYA shares?
During the previous two years, 63 institutional investors and hedge funds held shares of Akoya Biosciences, Inc.. The most heavily invested institutionals were:
Blue Water Life Science Advisors, LP: 4.7 M
BlackRock Funding, Inc. /DE: 1.58 M
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE: 790,000
GEODE CAPITAL MANAGEMENT, LLC: 561,609
STATE STREET CORP: 453,296
Parkman Healthcare Partners LLC: 376,131
-
What percentage of Akoya Biosciences, Inc. stock is owned by institutional investors?
24.43% of Akoya Biosciences, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at AKYA ?
Institutional investors have bought a total of 11.89 M shares in the last 24 months. This purchase volume represents approximately $25.09 M in transactions.